FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileRegencell Bioscience Holdings Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RGC
Regencell Bioscience Holdings Limited Stock AnalysisComprehensive stock analysis for Regencell Bioscience Holdings Limited (RGC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRGC
RGC
Regencell Bioscience Holdings Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RGC
  1. Home
  2. Stocks
  3. Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited

🇺🇸RGC•NASDAQ

Regencell Bioscience Holdings Limited

🇺🇸RGC•NASDAQ
Market cap
$2.07B

Your view on RGC

Mkt Cap
$2.07B
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Regencell Bioscience Holdings Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Yat-Gai Au
Headquarters
First Commercial Building, Causeway Bay, HK
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Yat-Gai Au
Headquarters
First Commercial Building, Causeway Bay, HK
Description

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Regencell Bioscience Holdings Limited. Starting points for Regencell Bioscience Holdings Limited: EPS -$0.02, beta 1.43 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Regencell Bioscience Holdings Limited. Trailing twelve-month EPS for Regencell Bioscience Holdings Limited stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026

Hold

Analyst ratings

4 ratings
  • Strong Buy0
  • Buy0
  • Hold4
  • Sell0
  • Strong Sell0
Recent rating and target changes (4)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Regencell Bioscience Holdings Limited. Regencell Bioscience Holdings Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RGC17 companies · 2 funds
Compare RGC with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
AMLXAmylyx Pharmaceuticals, Inc.HealthcareBiotechnology$3.3B
AXSMAxsome Therapeutics, Inc.HealthcareBiotechnology$6.8B
HRMYHarmony Biosciences Holdings, Inc.HealthcareBiotechnology$1.9B
LBRXLB Pharmaceuticals Inc Common StockHealthcareBiotechnology$1.3B
PRAXPraxis Precision Medicines, Inc.HealthcareBiotechnology$8.4B
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
ACB.TOAurora Cannabis Inc.HealthcareTSX$393.8M
ACURAcura Pharmaceuticals, Inc.HealthcareOTC$33,001
ACUSAcusphere, Inc.HealthcareOTC$49
AFP.AXAFT Pharmaceuticals LimitedHealthcareASX—
AGFAFDigicann Ventures Inc.HealthcareOTC$606,354
AGYTFAllergy Therapeutics plcHealthcareOTC$504.6M
AIDAAida Pharmaceuticals, Inc.HealthcareOTC$8,101
AKANAkanda Corp.HealthcareNASDAQ$10.1M
ALGWFAlliance Growers Corp.HealthcareOTC—
ALIDAllied Corp.HealthcareOTC$57,748
ALKSAlkermes plcHealthcareNASDAQ$7.6B
ALVOAlvotechHealthcareNASDAQ$1.5B
ETFs holding Regencell Bioscience Holdings Limited
TickerFundFund assets% of the fund
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF$10.4B in assets0.01%
GXCState Street SPDR S&P China ETF$441M in assets0.00%

Largest holders first, then the funds most concentrated in RGC.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Regencell Bioscience Holdings Limited, and how their positions are changing. At a $2.07B market value, institutional positions materially move Regencell Bioscience Holdings Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Regencell Bioscience Holdings Limited executives and directors. Shares of Regencell Bioscience Holdings Limited have traded between $0.09 and $83.60 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Regencell Bioscience Holdings Limited. Regencell Bioscience Holdings Limited is a $2.07B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Regencell Bioscience Holdings Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Regencell Bioscience Holdings Limited. Coverage tracks Regencell Bioscience Holdings Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Regencell Bioscience Holdings Limited.

RGC AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1